0001209191-21-056969.txt : 20210920
0001209191-21-056969.hdr.sgml : 20210920
20210920200338
ACCESSION NUMBER: 0001209191-21-056969
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210909
FILED AS OF DATE: 20210920
DATE AS OF CHANGE: 20210920
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Clem Kerry M
CENTRAL INDEX KEY: 0001883938
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31938
FILM NUMBER: 211264483
MAIL ADDRESS:
STREET 1: 420 SAW MILL RIVER ROAD
CITY: ARDSLEY
STATE: NY
ZIP: 10502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACORDA THERAPEUTICS INC
CENTRAL INDEX KEY: 0001008848
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 420 SAW MILL RIVER ROAD
CITY: ARDSLEY
STATE: NY
ZIP: 10502
BUSINESS PHONE: 914-347-4300
MAIL ADDRESS:
STREET 1: 420 SAW MILL RIVER ROAD
CITY: ARDSLEY
STATE: NY
ZIP: 10502
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2021-09-09
0
0001008848
ACORDA THERAPEUTICS INC
ACOR
0001883938
Clem Kerry M
420 SAW MILL RIVER ROAD
ARDSLEY
NY
10502
0
1
0
0
Chief Commercial Officer
Common Stock
11594
D
Employee Stock Option (right to buy)
158.10
2022-03-15
Common Stock
3000
D
Employee Stock Option (right to buy)
182.76
2023-03-06
Common Stock
3543
D
Employee Stock Option (right to buy)
236.28
2024-03-05
Common Stock
3543
D
Employee Stock Option (right to buy)
214.44
2025-03-04
Common Stock
3188
D
Employee Stock Option (right to buy)
213.18
2026-03-02
Common Stock
2159
D
Employee Stock Option (right to buy)
164.85
2027-03-01
Common Stock
1250
D
Employee Stock Option (right to buy)
146.10
2028-03-01
Common Stock
1967
D
Employee Stock Option (right to buy)
81.06
2029-03-08
Common Stock
1834
D
Employee Stock Option (right to buy)
14.46
2029-11-07
Common Stock
9168
D
Employee Stock Option (right to buy)
3.1572
2030-09-01
Common Stock
2501
D
Includes 550 unvested restricted stock awards and 6,675 unvested restricted stock unit awards issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. 275 of the restricted stock awards vest on December 1, 2021 and 275 vest on December 1, 2022, subject to continued service. The restricted stock units each represent a contingent right to one share of the Issuer's common stock, subject to continued service, vesting in installments of 20% and 40% on March 3, 2022 and September 3, 2022, respectively.
Options issued under the Issuer's 2006 Employee Incentive Plan. The shares subject to this option vested in installments and were fully vested on January 1, 2016.
Options issued under the Issuer's 2006 Employee Incentive Plan. The shares subject to this option vested in installments and were fully vested on January 1, 2017.
Options issued under the Issuer's 2006 Employee Incentive Plan. The shares subject to this option vested in installments and were fully vested on January 1, 2018.
Options issued under the Issuer's 2006 Employee Incentive Plan. The shares subject to this option vested in installments and were fully vested on January 1, 2019.
Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vested in installments and were fully vested on January 1, 2020.
Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vested in installments and were fully vested on January 1, 2021.
Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vest in equal quarterly installments over four years beginning on January 1, 2019, with the first quarterly installment vesting on April 1, 2019.
Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vest in equal quarterly installments over two years beginning on November 7, 2019, with the first quarterly installment vesting on February 7, 2020.
Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vest in equal quarterly installments over four years beginning on September 1, 2020, with the first quarterly installment vesting on December 1, 2020.
/s/ Kerry M. Clem
2021-09-20
EX-24.3_1009316
2
poa.txt
POA DOCUMENT
LIMITED POWER OF ATTORNEY FOR
SECTION 16 REPORTING OBLIGATIONS
Know all by these presents, that the undersigned's hereby makes, constitutes
and appoints ________ as the undersigned's true and lawful attorney-in-fact,
with full power and authority as hereinafter described on behalf of and in the
name, place and stead of the undersigned to:
(1) prepare, execute, acknowledge, deliver and file Forms 3, 4, and 5 (including
any amendments thereto) with respect to the securities of __________________, a
_________ corporation (the "Company"), with the United States Securities and
Exchange Commission, any national securities exchanges and the Company, as
considered necessary or advisable under Section 16(a) of the Securities Exchange
Act of 1934 and the rules and regulations promulgated thereunder, as amended
from time to time (the "Exchange Act");
(2) seek or obtain, as the undersigned's representative and on the undersigned's
behalf, information on transactions in the Company's securities from any third
party, including brokers, employee benefit plan administrators and trustees, and
the undersigned hereby authorizes any such person to release any such
information to the undersigned and approves and ratifies any such release of
information; and
(3) perform any and all other acts which in the discretion of such
attorney-in-fact are necessary or desirable for and on behalf of the undersigned
in connection with the foregoing.
The undersigned acknowledges that:
(1) this Power of Attorney authorizes, but does not require, such
attorney-in-fact to act in their discretion on information provided to such
attorney-in-fact without independent verification of such information;
(2) any documents prepared and/or executed by such attorney-in-fact on behalf of
the undersigned pursuant to this Power of Attorney will be in such form and will
contain such information and disclosure as such attorney-in-fact, in his or her
discretion, deems necessary or desirable;
(3) neither the Company nor such attorney-in-fact assumes (i) any liability for
the undersigned's responsibility to comply with the requirement of the Exchange
Act, (ii) any liability of the undersigned for any failure to comply with such
requirements, or (iii) any obligation or liability of the undersigned for profit
disgorgement under Section 16(b) of the Exchange Act; and
(4) this Power of Attorney does not relieve the undersigned from responsibility
for compliance with the undersigned's obligations under the Exchange Act,
including without limitation the reporting requirements under Section 16 of the
Exchange Act.
The undersigned hereby gives and grants the foregoing attorney-in-fact full
power and authority to do and perform all and every act and thing whatsoever
requisite, necessary or appropriate to be done in and about the foregoing
matters as fully to all intents and purposes as the undersigned might or could
do if present, hereby ratifying all that such attorney-in-fact of, for and on
behalf of the undersigned, shall lawfully do or cause to be done by virtue of
this Limited Power of Attorney.
This Power of Attorney shall remain in full force and effect until revoked by
the undersigned in a signed writing delivered to such attorney-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this _______ day of ___________, ___________.
_________________________________
Signature
_________________________________
Print Name
STATE OF
COUNTY OF
On this ___________ day of ____________, ______________, ________________
personally appeared before me, and acknowledged that s/he executed the foregoing
instrument for the purposes therein contained.
IN WITNESS WHEREOF, I have hereunto set my hand and official seal.
_________________________________
Notary Public
_________________________________
My Commission Expires: